Lithuania vs Panama: The number of people with susceptibility test result for rifampicin
Lithuania
465
in 2021
Panama
497
in 2021
Lithuania rank
82nd
Panama rank
79th
The number of people with susceptibility test result for rifampicin over time
- Lithuania
- Panama
How they compare
Panama currently reports 497 against 465 in Lithuania, a difference of 32.
That makes Panama's figure about 1.1 times Lithuania's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Lithuania ahead.
Lithuania ranks 82nd and Panama ranks 79th of 155 countries.
Lithuania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lithuania | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 777 | 477 | 300 | Lithuania |
| 2020s | 474 | 452.5 | 21.5 | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Lithuania or Panama?
- Panama, at 497 against 465 in Lithuania as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Lithuania and Panama?
- 32, with Panama ahead.
- How many years of comparable data are there for Lithuania and Panama?
- 5 years are reported by both, from 2017 to 2021.
- How do Lithuania and Panama rank globally for the number of people with susceptibility test result for rifampicin?
- Lithuania ranks 82nd and Panama ranks 79th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.